Apyx Medical study shows cellulite treatment improvement with dual approach

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. GOOGL
6. APGE
7. MU
8. HOOD
9. DFTX
10. RGNX

Go back to Apyx Medical study shows cellulite treatment improvement with dual approach
(NASDAQ: APYX) Delayed: 4.07 -0.04 (0.97%)
Previous Close $4.11    52 Week High $ 
Open $4.07    52 Week Low $ 
Day High $4.12    P/E N/A 
Day Low $3.93    EPS $ 
Volume 87,089